Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alpha Cognition, Inc

Clinical trials sponsored by Alpha Cognition, Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Alzheimer's drug aims to ease symptoms and help caregivers Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New Alzheimer's drug aims to ease symptoms and help caregivers

Symptom relief Recruiting now

This study tests the safety and tolerability of the drug Zunveyl in 150 adults aged 50 and older with mild to moderate Alzheimer's disease. Over 12 weeks, researchers will monitor side effects and whether the drug helps reduce neuropsychiatric symptoms like agitation or mood chan…

Phase 4 • Sponsor: Alpha Cognition, Inc • Aim: Symptom relief

Last updated Aug 30, 2026 00:00 UTC